| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 1 | +100.00% | +2.51% | -0.94% | +3.45% | +3.45% | — |
| 14d | 1 | +0.00% | -7.18% | -3.54% | -3.64% | -3.64% | — |
| 30d | 1 | +100.00% | +0.84% | +0.40% | +0.43% | +0.43% | — |
| 60d | 1 | +0.00% | -9.61% | +8.93% | -18.53% | -18.53% | — |
| 90d | 1 | +0.00% | -17.92% | +8.90% | -26.81% | -26.81% | — |
| 180d | 1(1 pending) | — | — | — | — | — | — |
| 1y | 1(1 pending) | — | — | — | — | — | — |
| 2y | 1(1 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| VKTX VIKING THERAPEUTICS, INC. | PURCHASE Chief Commercial Officer | 4,475 | $33.50 | $149.9K | 4,475 | Mar 10, 2026 | Mar 10, 2026 ↗ | View → |
| VKTX VIKING THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 180,000 | — | — | 180,000 | Jan 12, 2026 | Jan 26, 2026 ↗ | View → |